371 related articles for article (PubMed ID: 23079656)
1. Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia.
Sawai CM; Freund J; Oh P; Ndiaye-Lobry D; Bretz JC; Strikoudis A; Genesca L; Trimarchi T; Kelliher MA; Clark M; Soulier J; Chen-Kiang S; Aifantis I
Cancer Cell; 2012 Oct; 22(4):452-65. PubMed ID: 23079656
[TBL] [Abstract][Full Text] [Related]
2. The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.
Paternot S; Colleoni B; Bisteau X; Roger PP
Cell Cycle; 2014; 13(18):2879-88. PubMed ID: 25486476
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia.
Wang L; Wang J; Blaser BW; Duchemin AM; Kusewitt DF; Liu T; Caligiuri MA; Briesewitz R
Blood; 2007 Sep; 110(6):2075-83. PubMed ID: 17537993
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
5. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1).
Bagui TK; Jackson RJ; Agrawal D; Pledger WJ
Mol Cell Biol; 2000 Dec; 20(23):8748-57. PubMed ID: 11073976
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
9. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
Paternot S; Coulonval K; Dumont JE; Roger PP
J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225
[TBL] [Abstract][Full Text] [Related]
11. Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein.
Haller K; Wu Y; Derow E; Schmitt I; Jeang KT; Grassmann R
Mol Cell Biol; 2002 May; 22(10):3327-38. PubMed ID: 11971966
[TBL] [Abstract][Full Text] [Related]
12. Levels and interactions of p27, cyclin D3, and CDK4 during the formation and maintenance of the corpus luteum in mice.
Hampl A; Pacherník J; Dvorák P
Biol Reprod; 2000 May; 62(5):1393-401. PubMed ID: 10775192
[TBL] [Abstract][Full Text] [Related]
13. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
14. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
15. CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia.
Jena N; Sheng J; Hu JK; Li W; Zhou W; Lee G; Tsichlis N; Pathak A; Brown N; Deshpande A; Luo C; Hu GF; Hinds PW; Van Etten RA; Hu MG
Leukemia; 2016 May; 30(5):1033-43. PubMed ID: 26707936
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG
Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552
[TBL] [Abstract][Full Text] [Related]
17. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
[TBL] [Abstract][Full Text] [Related]
18. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin.
Bryja V; Pacherník J; Vondráček J; Souček K; Čajánek L; Horvath V; Holubcová Z; Dvořák P; Hampl A
Cell Prolif; 2008 Dec; 41(6):875-893. PubMed ID: 19040567
[TBL] [Abstract][Full Text] [Related]
19. CDK4 activity in mouse embryos expressing a single D-type cyclin.
Ciemerych MA; Yu Q; Szczepanska K; Sicinski P
Int J Dev Biol; 2008; 52(2-3):299-305. PubMed ID: 18311721
[TBL] [Abstract][Full Text] [Related]
20. P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes.
Bagui TK; Mohapatra S; Haura E; Pledger WJ
Mol Cell Biol; 2003 Oct; 23(20):7285-90. PubMed ID: 14517297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
